|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 409/10 | (2006.01) |
| A61K 31/351 | (2006.01) | ||
| A61K 31/381 | (2006.01) | ||
| A61P 3/08 | (2006.01) |
| (11) | Number of the document | 3053919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16152411.1 |
| Date of filing the European patent application | 2016-01-22 | |
| (97) | Date of publication of the European application | 2016-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201510059262 | 2015-02-04 | CN |
| (72) |
WANG, Meng , CN
ZHANG, Liang , CN
|
| (73) |
Shanghai Desano Pharmaceuticals
Investment Co., Ltd ,
1479 Zhangheng Road
Pudong New Area, Shanghai 201203,
CN
Shanghai Desano Chemical Pharmaceutical Co., Ltd , Room 338, Building 2 No. 456 Liangxin Road Leogang Town Pudong District, Shanghai 201302, CN |
| (54) | CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE AND PREPARATION METHOD THEREOF |
| CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE AND PREPARATION METHOD THEREOF |